JSKN033: Clinical Trials

1 trial of JSKN033, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow JSKN033: new trials by email Literature Review of JSKN033 trials Research Report on JSKN033

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer
JSKN033, Docetaxel, Topotecan - Recurrent or Metastatic Cervical Cancer
Phase 3Not yet recruitingJiangsu Alphamab Biopharmaceuticals Co., Ltd3682026-09-012026-09-01

Conditions studied

Recurrence (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd (1)

Countries

China (1)